337 related articles for article (PubMed ID: 16117902)
1. [Transdermal fentanyl for the management of cancer pain: a survey of 4492 patients].
Yu SY; Sun Y; Wu YL; Qin SK; Xie GR; Liu SJ; Sui GJ; Zhang HC
Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):369-72. PubMed ID: 16117902
[TBL] [Abstract][Full Text] [Related]
2. [Transdermal fentanyl for the management of cancer pain: a survey of 1,664 elderly patients].
Yu SY; Sun Y; Zhang HC; Wu YL; Qin SK; Xie GR; Liu SJ; Sui G
Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(22):1931-5. PubMed ID: 14703423
[TBL] [Abstract][Full Text] [Related]
3. From codeine to transdermal fentanyl for cancer pain control: a safety and efficacy clinical trial.
Mystakidou K; Befon S; Kouskouni E; Gerolymatos K; Georgaki S; Tsilika E; Vlahos L
Anticancer Res; 2001; 21(3C):2225-30. PubMed ID: 11501851
[TBL] [Abstract][Full Text] [Related]
4. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
5. [Transdermal fentanyl in treating severe painful mucositis caused by autologous hematopoietic stem cell transplantation].
Huang HQ; Cai QQ; Lin XB; Wang BF; Bu Q; Gao Y; Peng YL
Ai Zheng; 2007 Apr; 26(4):390-3. PubMed ID: 17430658
[TBL] [Abstract][Full Text] [Related]
6. [Effects of sustained release morphine hydrochloride tablets in management of cancer pain: a survey of 567 patients].
Yu SY; Qiu H; Ma ZS; Chen J; Zhang Y; Chen LZ; Wang DL; Ma ZY
Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):450-5. PubMed ID: 15061959
[TBL] [Abstract][Full Text] [Related]
7. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain.
van Seventer R; Smit JM; Schipper RM; Wicks MA; Zuurmond WW
Curr Med Res Opin; 2003; 19(6):457-69. PubMed ID: 14594516
[TBL] [Abstract][Full Text] [Related]
8. Early conversion from oral morphine to transdermal fentanyl in patients with cancer pain.
Tani M; Fuku A; Terashita S; Kashiwagi H; Yukawa H; Yamaue H
Hepatogastroenterology; 2008; 55(86-87):1545-8. PubMed ID: 19102339
[TBL] [Abstract][Full Text] [Related]
9. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.
Wirz S; Wittmann M; Schenk M; Schroeck A; Schaefer N; Mueller M; Standop J; Kloecker N; Nadstawek J
Eur J Pain; 2009 Aug; 13(7):737-43. PubMed ID: 18977159
[TBL] [Abstract][Full Text] [Related]
11. Transdermal fentanyl in the management of children with chronic severe pain: results from an international study.
Finkel JC; Finley A; Greco C; Weisman SJ; Zeltzer L
Cancer; 2005 Dec; 104(12):2847-57. PubMed ID: 16284992
[TBL] [Abstract][Full Text] [Related]
12. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
[TBL] [Abstract][Full Text] [Related]
13. Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain.
Tawfik MO; Bryuzgin V; Kourteva G;
Curr Med Res Opin; 2004 Mar; 20(3):259-67. PubMed ID: 15025835
[TBL] [Abstract][Full Text] [Related]
14. [Feasibility to treat pediatric cancer pain with analgesics for adults and their efficacy].
Zhen ZJ; Sun XF; Xia Y; Ling JY; Zheng L; Luo WB; Lin H
Ai Zheng; 2007 Aug; 26(8):866-9. PubMed ID: 17697549
[TBL] [Abstract][Full Text] [Related]
15. A Phase III study to assess the clinical utility of low-dose fentanyl transdermal system in patients with chronic nonmalignant pain.
Otis J; Rothman M
Curr Med Res Opin; 2006 Aug; 22(8):1493-501. PubMed ID: 16870074
[TBL] [Abstract][Full Text] [Related]
16. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
[TBL] [Abstract][Full Text] [Related]
17. Impact of transdermal fentanyl on quality of life in rheumatoid arthritis.
Berliner MN; Giesecke T; Bornhövd KD
Clin J Pain; 2007; 23(6):530-4. PubMed ID: 17575494
[TBL] [Abstract][Full Text] [Related]
18. [Home palliative care--2 case reports: a long-term cancer pain management with transdermal fentanyl].
Fujimoto M; Sakuyama T; Mizutani Y; Kuroda T; Yanaga K
Gan To Kagaku Ryoho; 2004 Dec; 31 Suppl 2():190-3. PubMed ID: 15645768
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
Clark AJ; Ahmedzai SH; Allan LG; Camacho F; Horbay GL; Richarz U; Simpson K
Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
[TBL] [Abstract][Full Text] [Related]
20. Transdermal fentanyl in cancer patients with moderate-to-severe pain: a prospective examination.
Iconomou G; Viha A; Vagenakis AG; Kalofonos HP
Anticancer Res; 2000; 20(6C):4821-4. PubMed ID: 11205226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
